Work

Phase 1b study evaluating the safety and efficacy of ABBV-383 monotherapy in patients with light chain amyloidosis PA149 (#178)

Year: 2024

Type: other

DOI: 10.26226/m.65f9bf8ae6f73964e1d4ed0d

Authors: Vaishali Sanchorawala, Shaji Kumar, Simon Gibbs, Efstathios Kastritis, Arnaud Jaccard, David Hoffman, Akshanth Polepally, Rebecca Hill, Leanne Lash, Chetasi Talati, Orlando Bueno, Giovanni Palladini

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396792937

Cites:

Cited by:

Related to: 10